Overview

Xealth provides a digital prescribing and analytics platform designed for healthcare providers, including physicians and care teams. This platform enables medical professionals to prescribe digital health content, applications, and services just like traditional medications, which helps to enhance patient education and engagement. By extending the interaction between patients and physicians beyond the examination room, Xealth aims to improve patient outcomes and streamline care processes. The company operates on a subscription-based model, where healthcare institutions pay for access to the platform. This model not only generates revenue but also allows healthcare providers to gain insights into patient engagement and treatment effectiveness through the platform's analytics capabilities. Xealth differentiates itself from competitors by focusing on integrating digital health solutions into the existing healthcare workflow, making it easier for providers to adopt and utilize these tools.

Simplify's Take

What believers are saying

• Recent investment from Morningside Ventures boosts Xealth's growth and platform enhancement.
• Partnerships with major EHR vendors expand Xealth's integration and market reach.
• The rise of telehealth and remote monitoring tools aligns with Xealth's offerings.

What critics are saying

• Increased competition from new digital health startups may impact Xealth's market share.
• Rapid technological advancements require continuous platform updates, straining resources.
• Potential data privacy concerns could arise with expanded digital health offerings.

What makes Xealth unique

• Xealth integrates digital health tools directly into EHR workflows for seamless clinician use.
• The platform offers analytics for patient engagement and treatment efficacy insights.
• Xealth's subscription model provides scalable solutions for healthcare institutions.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$52.5M

Meets

Industry Average

Funded Over

4 Rounds

$24,000,000

Series B

Sep 2021

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.

Series B Funding Comparison

Below Average

Industry standards

Ind Avg. $35M

$4M

$24M

$30M

$45M

$65M

$100M

View all funding stages